Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 6Triple Negative Breast Neoplasms 4Breast Neoplasms 4Sarcoma 3Stomach Neoplasms 2Dendritic Cell Sarcoma, Interdigitating 2Wilms Tumor 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Multiple Myeloma 1Melanoma 1Mediastinal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Leukemia 1Hodgkin Disease 1Fallopian Tube Neoplasms 1Enteropathy-Associated T-Cell Lymphoma 1Endometrial Neoplasms 1Carcinoma, Pancreatic Ductal 1Carcinoma 1Ann Arbor Stage II Mantle Cell Lymphoma 1Advanced Gastric Cancer 1

Interventions

Doxorubicin 1Cyclophosphamide 1Cisplatin 1Chemoradiotherapy 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Thymoma × Doxorubicin × Clear all
NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2/3 Not yet recruiting
116 enrolled
Thoracic

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡